Search filters

List of works by Howard A Burris

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial ⬇️

scientific article published on July 16, 2012

Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor

scientific article

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

scientific article

Correcting the ASCO position on phase I clinical trials in cancer

scientific article published on 01 February 2020

Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.

scientific article

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib ⬇️

scientific article published on November 8, 2012

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors ⬇️

scientific article published on November 22, 2012

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial ⬇️

scientific article published on July 16, 2012

Paulina is supported by:

About Paulina

Help